ZA997227B - Process and intermediates for growth hormone secretagogues. - Google Patents

Process and intermediates for growth hormone secretagogues.

Info

Publication number: ZA997227B
Authority: ZA; South Africa
Prior art keywords: intermediates; growth hormone; hormone secretagogues; secretagogues; growth
Prior art date: 1998-11-23

Application number

ZA9907227A

Other languages

English (en)

Inventor

Charles Kwok-Fung Chiu

David Andrew Griffith

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-23

Filing date

1999-11-22

Publication date

2001-05-22

1999-11-22 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2001-05-22 Publication of ZA997227B publication Critical patent/ZA997227B/xx

Links

239000003324 growth hormone secretagogue Substances 0.000 title 1
239000000543 intermediate Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D247/00—Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups C07D229/00 - C07D245/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Peptides Or Proteins (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

ZA9907227A 1998-11-23 1999-11-22 Process and intermediates for growth hormone secretagogues. ZA997227B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10952498P	1998-11-23	1998-11-23

Publications (1)

Publication Number	Publication Date
ZA997227B true ZA997227B (en)	2001-05-22

Family

ID=22328134

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9907227A ZA997227B (en)	1998-11-23	1999-11-22	Process and intermediates for growth hormone secretagogues.

Country Status (20)

Country	Link
US (4)	US6297380B1 (de)
EP (1)	EP1004583B1 (de)
JP (2)	JP3488155B2 (de)
KR (1)	KR20000035568A (de)
CN (1)	CN1255498A (de)
AR (1)	AR019498A1 (de)
AT (1)	ATE274517T1 (de)
AU (1)	AU5958499A (de)
BR (1)	BR9905732A (de)
CA (1)	CA2290252C (de)
DE (1)	DE69919663T2 (de)
DK (1)	DK1004583T3 (de)
ES (1)	ES2226297T3 (de)
HU (1)	HUP9904384A3 (de)
ID (1)	ID23852A (de)
IL (1)	IL133043A0 (de)
PL (1)	PL336710A1 (de)
PT (1)	PT1004583E (de)
TR (1)	TR199902879A2 (de)
ZA (1)	ZA997227B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998058947A1 (en) *	1997-06-25	1998-12-30	Pfizer Inc.	Dipeptide derivatives as growth hormone secretagogues
US6297380B1 (en)	1998-11-23	2001-10-02	Pfizer Inc.	Process and intermediates for growth hormone secretagogues
US20040077605A1 (en) *	2001-06-20	2004-04-22	Salvati Mark E.	Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1854798A3 (de) *	2000-09-19	2007-11-28	Bristol-Myers Squibb Company	Kondensierte heterozyklische Succinimid-Verbindungen und Analoga daraus, Modulatoren der nuklearen Hormonrezeptorfunktion
US6710064B2 (en)	2000-12-01	2004-03-23	Bristol-Myers Squibb Co.	Hydantoin compounds useful as anti-inflammatory agents
US20040087548A1 (en)	2001-02-27	2004-05-06	Salvati Mark E.	Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
WO2003011824A1 (en)	2001-07-31	2003-02-13	Bristol-Myers Squibb Company	Bicyclic modulators of androgen receptor function
US7087636B2 (en) *	2001-12-19	2006-08-08	Bristol-Myers Squibb Company	Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
US7405234B2 (en)	2002-05-17	2008-07-29	Bristol-Myers Squibb Company	Bicyclic modulators of androgen receptor function
WO2004045518A2 (en)	2002-11-15	2004-06-03	Bristol-Myers Squibb Company	Open chain prolyl urea-related modulators of androgen receptor function
US7820702B2 (en)	2004-02-04	2010-10-26	Bristol-Myers Squibb Company	Sulfonylpyrrolidine modulators of androgen receptor function and method
US7625923B2 (en)	2004-03-04	2009-12-01	Bristol-Myers Squibb Company	Bicyclic modulators of androgen receptor function
US7696241B2 (en)	2004-03-04	2010-04-13	Bristol-Myers Squibb Company	Bicyclic compounds as modulators of androgen receptor function and method
ES2690205T3 (es) *	2006-04-13	2018-11-19	Neurotech Pharmaceuticals Co., Ltd.	Composición farmacéutica para tratar o prevenir enfermedades inflamatorias
EP2039695A4 (de) *	2006-07-11	2010-09-15	Takeda Pharmaceutical	Bicyclische heterocylische verbindung und deren verwendung
IL300309B2 (en) *	2020-08-12	2026-03-01	Genentech Inc	Synthesis of quinazoline compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4746755A (en)	1986-05-06	1988-05-24	The Dow Chemical Company	Preparation of hydrantoic acids and hydantoins
DE3643748A1 (de)	1986-12-20	1988-06-30	Hoechst Ag	Bicylische imide, verfahren zu ihrer herstellung sowie ihre verwendung im pflanzenschutz
US4868061A (en)	1988-05-19	1989-09-19	The Standard Oil Company	Olefinic aryl oxime derivatives of hydantoins
TW432073B (en)	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
GB2324087A (en) *	1997-04-10	1998-10-14	Merck & Co Inc	Preparation of (S)-3-Carbethoxy-3-benzylpiperidine
WO1998058947A1 (en) *	1997-06-25	1998-12-30	Pfizer Inc.	Dipeptide derivatives as growth hormone secretagogues
US6358951B1 (en) *	1998-08-21	2002-03-19	Pfizer Inc.	Growth hormone secretagogues
US6297380B1 (en)	1998-11-23	2001-10-02	Pfizer Inc.	Process and intermediates for growth hormone secretagogues

1999
- 1999-11-12 US US09/438,911 patent/US6297380B1/en not_active Expired - Fee Related
- 1999-11-18 EP EP99309203A patent/EP1004583B1/de not_active Expired - Lifetime
- 1999-11-18 JP JP32771999A patent/JP3488155B2/ja not_active Expired - Fee Related
- 1999-11-18 DE DE69919663T patent/DE69919663T2/de not_active Expired - Fee Related
- 1999-11-18 DK DK99309203T patent/DK1004583T3/da active
- 1999-11-18 PT PT99309203T patent/PT1004583E/pt unknown
- 1999-11-18 ES ES99309203T patent/ES2226297T3/es not_active Expired - Lifetime
- 1999-11-18 IL IL13304399A patent/IL133043A0/xx unknown
- 1999-11-18 AT AT99309203T patent/ATE274517T1/de not_active IP Right Cessation
- 1999-11-19 AR ARP990105921A patent/AR019498A1/es not_active Application Discontinuation
- 1999-11-19 KR KR1019990051443A patent/KR20000035568A/ko not_active Ceased
- 1999-11-22 ID IDP991083D patent/ID23852A/id unknown
- 1999-11-22 CA CA002290252A patent/CA2290252C/en not_active Expired - Fee Related
- 1999-11-22 HU HU9904384A patent/HUP9904384A3/hu unknown
- 1999-11-22 AU AU59584/99A patent/AU5958499A/en not_active Abandoned
- 1999-11-22 ZA ZA9907227A patent/ZA997227B/xx unknown
- 1999-11-23 CN CN99124487A patent/CN1255498A/zh active Pending
- 1999-11-23 BR BR9905732-8A patent/BR9905732A/pt not_active IP Right Cessation
- 1999-11-23 TR TR1999/02879A patent/TR199902879A2/xx unknown
- 1999-11-23 PL PL99336710A patent/PL336710A1/xx not_active Application Discontinuation
2001
- 2001-08-03 US US09/922,040 patent/US6465651B2/en not_active Expired - Fee Related
2002
- 2002-06-14 JP JP2002174642A patent/JP2003012672A/ja active Pending
- 2002-07-31 US US10/209,834 patent/US6603002B2/en not_active Expired - Fee Related
2003
- 2003-06-05 US US10/456,405 patent/US6686471B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US6686471B2 (en)	2004-02-03
US20030225280A1 (en)	2003-12-04
ATE274517T1 (de)	2004-09-15
AU5958499A (en)	2000-05-25
HUP9904384A2 (hu)	2000-08-28
CN1255498A (zh)	2000-06-07
US20030088097A1 (en)	2003-05-08
CA2290252C (en)	2004-08-24
DE69919663T2 (de)	2005-09-01
JP3488155B2 (ja)	2004-01-19
JP2003012672A (ja)	2003-01-15
PL336710A1 (en)	2000-06-05
PT1004583E (pt)	2004-12-31
DK1004583T3 (da)	2004-12-13
US6297380B1 (en)	2001-10-02
BR9905732A (pt)	2001-03-20
EP1004583A3 (de)	2000-06-14
DE69919663D1 (de)	2004-09-30
EP1004583A2 (de)	2000-05-31
EP1004583B1 (de)	2004-08-25
US20020010335A1 (en)	2002-01-24
US6465651B2 (en)	2002-10-15
US6603002B2 (en)	2003-08-05
ID23852A (id)	2000-05-25
HUP9904384A3 (en)	2002-04-29
HU9904384D0 (en)	2000-01-28
JP2000159770A (ja)	2000-06-13
AR019498A1 (es)	2002-02-20
IL133043A0 (en)	2001-03-19
KR20000035568A (ko)	2000-06-26
TR199902879A2 (xx)	2000-06-21
CA2290252A1 (en)	2000-05-23
ES2226297T3 (es)	2005-03-16

Publication	Publication Date	Title
ZA987385B (en)	2000-04-18	Growth hormone secretagogues.
AU6772996A (en)	1997-03-12	2-acylaminopropanamides as growth hormone secretagogues
ZA9811407B (en)	2000-07-13	Crystalline teriparatide.
MXPA01002538A (es)	2003-10-15	Fertilizante foliar y metodo para utilizar el mismo.
ZA966891B (en)	1998-02-16	2-acylaminopropanamines as growth hormone secretagogues.
IL154115A0 (en)	2003-07-31	Process for the preparation of growth hormone secretagogues
AU6606601A (en)	2001-12-24	Growth hormone secretagogues
ZA997227B (en)	2001-05-22	Process and intermediates for growth hormone secretagogues.
CZ20012118A3 (cs)	2001-09-12	Způsob výroby 3-alkanoylindolu a 3-alkylindolu
GB2333521B (en)	2000-04-26	Nitride crystal growth method
SG118060A1 (en)	2006-01-27	Process for preparation of pyrazoloÄ4,3-dÜpyrimidin-7-ones and intermediates thereof
IL144350A0 (en)	2002-05-23	Growth hormone secretagogues
ZA9711523B (en)	1999-06-22	Continuous fermentation process
EP1126854A4 (de)	2002-09-04	Benzoazepine und deren analoge als mittel die die sekretion des wachstumshormone fördern
ZA200000888B (en)	2001-08-23	Process for preparing growth hormone secretagogues.
IL145220A0 (en)	2002-06-30	Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
ZA979094B (en)	1998-05-11	Placental-derived prostate growth factors.
EP1112071A4 (de)	2003-03-19	Substanzen zur förderung der sekretion der wachstumshormone
ZA982850B (en)	1999-10-04	Processes and intermediates for preparing 2-fluorothiophene derivatives.
HUP0003788A3 (en)	2001-05-28	Azacycloalkylalkanoyl pseudotetrapeptides intermediates and processes for preparation thereof
SI1004583T1 (en)	2004-12-31	Process and hydantoin intermediates for the synthesis of growth hormone secretagogues
HUP9800619A1 (en)	2000-07-28	Fermentation process
GB2343642B (en)	2003-02-26	Improved fastening method
HU9900121D0 (en)	1999-03-29	Process for producing naphthyridones and intermediates
ZA971119B (en)	1997-08-25	Processes for preparing intermediates.